EGeen International, Inc. is a premier global Contract Research Organization (CRO) specializing in fast, high-quality, and cost-effective clinical trial management services for biotech and pharmaceutical companies. With a strong global presence and extensive local site networks, EGeen leverages its expertise to deliver timely patient recruitment and comprehensive oversight of clinical trial operations, ensuring the highest regulatory standards are met. Known for its Generic Drug Development (GDD) Program, EGeen utilizes the cost-effective European trial environment to support worldwide filings and approvals of generic pharmaceutical products.
Under the leadership of CEO Mr. Rauno Oja and founder Dr. Kalev Kask, EGeen has established itself as a trusted trial partner of choice, offering a range of services from patient recruitment and trial design to regulatory affairs and data management. With a focus on rapid response, quality outcomes, and operational dedication, EGeen is committed to helping companies achieve their clinical end goals in a rapid and efficient manner. With a diverse therapeutic area expertise including cardiology, oncology, neurology, and dermatology, EGeen continues to drive drug development and contribute to advancements in the healthcare industry.
Generated from the website